Cargando…
Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)
Introduction: Preclinical studies have demonstrated the possible role of beta-adrenergic receptors in pancreatic ductal adenocarcinoma (PDAC) tumor invasion and migration. The current study aimed to explore the possible association between survival outcomes and beta-blocker (BB) exposure in patients...
Autores principales: | Le Bozec, Antoine, Brugel, Mathias, Djerada, Zoubir, Ayad, Marya, Perrier, Marine, Carlier, Claire, Botsen, Damien, Nazeyrollas, Pierre, Bouché, Olivier, Slimano, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235451/ https://www.ncbi.nlm.nih.gov/pubmed/37274119 http://dx.doi.org/10.3389/fphar.2023.1137791 |
Ejemplares similares
-
Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients
por: Callon, Sidonie, et al.
Publicado: (2023) -
Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX)
por: Martin, Pierre, et al.
Publicado: (2022) -
Impact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis
por: Laures, Nicolas, et al.
Publicado: (2022) -
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients
por: Botsen, Damien, et al.
Publicado: (2018) -
Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels
por: Amroun, Koceila, et al.
Publicado: (2022)